| Bioactivity | Antiflammin-1 is an anti-inflammatory peptide 1 (MQMKKVLDS). Antiflammin-1 is a derivative of uteroglobin. Antiflammin-1 has anti-inflammatory and antifibrotic actions in bleomycin (HY-108345)-induced lung injury[1][2][3]. |
| Invitro | Antiflammin-1 (10 μM) 可抑制 TGF-β1 诱导的 NIH3T3 细胞增殖,该增殖由 uteroglobin 受体介导[1]。 0 --> Antiflammin-1 相关抗体: |
| In Vivo | Antiflammin-1 (2-10 mg/kg,腹腔注射,每天,持续 6 天) 可降低博莱霉素治疗小鼠的 TNF-α 和 IL-1β 水平。 Antiflammin-1 在博来霉素 (HY-108345) 诱导的肺损伤中具有抗炎和抗纤维化作用[1]。 |
| Name | Antiflammin-1 |
| CAS | 118850-71-8 |
| Sequence | Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser |
| Shortening | MQMKKVLDS |
| Formula | C45H82N12O14S2 |
| Molar Mass | 1079.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu W, et al. Antiflammin-1 attenuates bleomycin-induced pulmonary fibrosis in mice. Respir Res. 2013 Oct 8;14(1):101. [2]. Camussi G, et al. Antiinflammatory peptides (antiflammins) inhibit synthesis of platelet-activating factor, neutrophil aggregation and chemotaxis, and intradermal inflammatory reactions. J Exp Med. 1990 Mar 1;171(3):913-27. [3]. Martínez Leo EE, et al. Biopeptides with antioxidant and anti-inflammatory potential in the prevention and treatment of diabesity disease. Biomed Pharmacother. 2016 Oct;83:816-826. |